Table I.
Baseline characteristics of study participants (n=205).
Characteristics | Frequency (n) | Percentage (%) | |
---|---|---|---|
Age in years (mean ± SD) | 32.96±7.7 | ||
Age range | 23 – 55 | ||
Gender | Male | 66 | 42.9% |
Female | 117 | 57.1% | |
Comorbidities | Diabetes | 23 | 11.2% |
Hypertension | 25 | 12.2% | |
Asthma | 2 | 1.0% | |
Tested positive for COVID-19 | Yes | 40 | 19.5% |
No | 165 | 80.5% | |
Overall experienced symptoms | Yes | 60 | 29.3% |
No | 145 | 70.7% |
In terms of post-vaccination symptoms, the distribution of acute side effects is presented in Fig.1.